Skip to Content
 

News: Breast Cancer Research Program

Pal named to cancer research national leadership posts

Monday, December 28th, 2020

Tuya Pal, MD, Ingram Professor of Cancer Research and associate director for Cancer Health Disparities at Vanderbilt-Ingram Cancer Center, has been named to two cancer research leadership posts.

New therapeutic target for lung cancer

Thursday, November 12th, 2020

Continuous activation of cell surface receptors increases signaling that can promote oncogenic transformation. One receptor, EphA2, has been identified as a driver of lung cancer, but its interacting partners are not well characterized.

Park named director of Hematology and Oncology at VICC

Wednesday, October 21st, 2020

After serving as interim director since Jan. 1, Ben Ho Park, MD, PhD, Donna S. Hall Professor of Breast Cancer Research at Vanderbilt University Medical Center, has been named director of the Division of Hematology and Oncology.

Balko lands Mary Kay Foundation grant for breast cancer research

Thursday, December 5th, 2019

Vanderbilt-Ingram Cancer Center’s Justin Balko, PharmD, PhD, has received a $100,000 research grant from the Mary Kay Foundation.

Pietenpol, Wilson land Komen cancer research support

Thursday, October 24th, 2019

Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.

Study backs genetic testing for all metastatic breast cancer patients

Friday, September 6th, 2019

Testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies.

Grant strengthens breast cancer research efforts

Saturday, August 31st, 2019

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.

Encephalitis identified as rare toxicity of immunotherapy treatment

Monday, July 22nd, 2019

Researchers are chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies.

A critical factor for wound healing

Friday, July 19th, 2019

Vanderbilt-Ingram Cancer Center scientists have discovered a role for a tumor suppressor protein in skin wound healing.

Research team documents potential new treatment path for breast cancer

Friday, January 18th, 2019

Immunotherapies that take off the “brakes” on the adaptive anti-tumor response have worked well in melanoma and lung cancer but less so in breast cancers. That could change.

Next Page »